1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    A businessperson sits at his desk in a cold office with snow and ice all around him and a frozen beard.
    Healthcare Shares

    Why is the Imugene share price on ice today?

    | Brooke Cooper

    The Imugene share price isn't going anywhere on Monday.

    Read more »

    Two researchers discussing results of a study with each other.
    Share Gainers

    Imugene share price leaps 5% on trial news

    | Zach Bristow

    The HER-Vaxx story continues today with another positive update from the immuno-oncology company.

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    What's going on with the Imugene share price on Thursday?

    | Monica O'Shea

    How is Imugene's Vaxinia trial going?

    Read more »

    Rising share price chart.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    These ASX 200 shares posted the biggest gains on Wednesday.

    Read more »

    A scientist examining test results.
    Earnings Results

    Net loss doubles in FY22, so what's with the Imugene share price today?

    | Raymond Jang

    The biotech company released its full-year results today.

    Read more »

    Boy looks quizzical standing in front of a graph.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    These ASX 200 shares outperformed all others on Tuesday.

    Read more »

    A disappointed lab researcher sits in her lab looking at her clipboard with her hand to her face as she worries about the Imugene share price today
    Healthcare Shares

    The Imugene share price has tumbled 18% since the company's last update. What's happening?

    | Bronwyn Allen

    The Imugene share price finished the session on Tuesday at 25 cents -- down 3.85% -- as the broader market…

    Read more »

    share price high, all time record, record share price, highest, price rise, increase, up,
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    These 10 ASX 200 shares outperformed all others on Wednesday.

    Read more »

    a group of three people carry a large block to line it up in ascending order with two other blocks nearby.
    Share Market News

    Here are the 3 most heavily traded ASX 200 shares on Wednesday

    | Sebastian Bowen

    Our most traded ASX 200 share today is up 10%.

    Read more »

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    Share Gainers

    Why Graincorp, Imugene, iSelect, and Mayne Pharma shares are racing higher

    | James Mickleboro

    These ASX shares are on form on Wednesday...

    Read more »

    A man in a wheelchair stretches both arms into the air in success.
    Healthcare Shares

    Imugene share price lifts 11% on clinical trial update

    | Aaron Teboneras

    Imugene shares are flying higher today.

    Read more »

    Businessman cheering at desk with arms in the air
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Brooke Cooper

    These ten ASX 200 shares outperformed all others on Monday.

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note